IL110254A - The use of tertiary ketopenalkylamines in the manufacture of drugs that lower the level of certain new tertiary cholesterololactofenalkylamines - Google Patents

The use of tertiary ketopenalkylamines in the manufacture of drugs that lower the level of certain new tertiary cholesterololactofenalkylamines

Info

Publication number
IL110254A
IL110254A IL110254A IL11025494A IL110254A IL 110254 A IL110254 A IL 110254A IL 110254 A IL110254 A IL 110254A IL 11025494 A IL11025494 A IL 11025494A IL 110254 A IL110254 A IL 110254A
Authority
IL
Israel
Prior art keywords
methyl
phenyl
allyl
bromo
amino
Prior art date
Application number
IL110254A
Other languages
English (en)
Hebrew (he)
Other versions
IL110254A0 (en
Inventor
Johannes Aebi
Philipe Guerry
Synese Jolidon
Olivier Morand
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL110254A0 publication Critical patent/IL110254A0/xx
Publication of IL110254A publication Critical patent/IL110254A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL110254A 1993-07-14 1994-07-08 The use of tertiary ketopenalkylamines in the manufacture of drugs that lower the level of certain new tertiary cholesterololactofenalkylamines IL110254A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH210793 1993-07-14
CH132094 1994-04-28

Publications (2)

Publication Number Publication Date
IL110254A0 IL110254A0 (en) 1994-10-21
IL110254A true IL110254A (en) 1998-04-05

Family

ID=25687322

Family Applications (1)

Application Number Title Priority Date Filing Date
IL110254A IL110254A (en) 1993-07-14 1994-07-08 The use of tertiary ketopenalkylamines in the manufacture of drugs that lower the level of certain new tertiary cholesterololactofenalkylamines

Country Status (22)

Country Link
US (3) US5495048A (fr)
EP (1) EP0636367B1 (fr)
JP (1) JP2519022B2 (fr)
KR (1) KR100312441B1 (fr)
CN (1) CN1087934C (fr)
AT (1) ATE191142T1 (fr)
AU (1) AU684507B2 (fr)
CA (1) CA2126518C (fr)
CZ (1) CZ288518B6 (fr)
DE (1) DE59409248D1 (fr)
DK (1) DK0636367T3 (fr)
ES (1) ES2144471T3 (fr)
GR (1) GR3033645T3 (fr)
HU (1) HUT70835A (fr)
IL (1) IL110254A (fr)
NO (1) NO309924B1 (fr)
NZ (1) NZ260968A (fr)
PH (1) PH31092A (fr)
PT (1) PT636367E (fr)
RU (1) RU2141942C1 (fr)
TW (1) TW438774B (fr)
UA (1) UA37199C2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2190708A1 (fr) * 1995-12-08 1997-06-09 Johannes Aebi Derives de substitution aminoalkyles de composes benzo-heterocycliques
CA2190699A1 (fr) 1995-12-08 1997-06-09 Johannes Aebi Amines tertiaires
CA2415551C (fr) 2000-07-18 2007-09-25 Jean Ackermann Derives d'aniline
CZ2003451A3 (cs) 2000-08-16 2003-10-15 F. Hoffmann-La Roche Ag Nové deriváty aminocyklohexanu
US6964974B2 (en) 2000-09-08 2005-11-15 Hoffmann-La Roche Inc. 2,3-oxidosqualene-lanosterol cyclase inhibitors
US6503907B2 (en) 2000-11-28 2003-01-07 Hoffmann-La Roche Inc. Indole and dihydroindole derivatives
US6706751B2 (en) 2000-12-21 2004-03-16 Hoffman-La Roche Inc. Dihydroindole and tetrahydroquinoline derivatives
IL162104A0 (en) * 2001-12-12 2005-11-20 Hoffmann La Roche Substituted cyclohexane derivatives
US7012077B2 (en) * 2001-12-20 2006-03-14 Hoffmann-La Roche Inc. Substituted cyclohexane derivatives
US6727277B1 (en) 2002-11-12 2004-04-27 Kansas State University Research Foundation Compounds affecting cholesterol absorption
TW200524849A (en) * 2003-07-02 2005-08-01 Hoffmann La Roche Hydroxyalkylamide derivatives
JP4339890B2 (ja) * 2003-09-22 2009-10-07 エフ．ホフマン−ラ ロシュ アーゲー アミノアルキルアミド置換シクロヘキシル誘導体
CN101583593A (zh) * 2006-11-13 2009-11-18 辉瑞产品公司 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途
CN108530390B (zh) * 2017-03-06 2020-04-21 西南化工研究设计院有限公司 一种4-羟基二苯甲酮的烷基化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3647863A (en) * 1968-11-25 1972-03-07 Richardson Merrell Inc Aminoalkoxy-triphenyl ethylenes and the salts thereof
US3928449A (en) * 1969-04-03 1975-12-23 Sandoz Ag Aminoalkoxy-terphenyls and the salts thereof
CA2016738A1 (fr) * 1989-06-08 1990-12-08 Philippe Guerry Derives d'aminoalkylbenzene substitues
CA2020888A1 (fr) * 1989-07-27 1991-01-28 Philippe Guerry Derives d'aminoalkoxybenzene substitues
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2044533A1 (fr) * 1990-06-29 1991-12-30 Philippe Guerry Derives aminoalkylbiphenyliques substitues
US5239084A (en) * 1990-06-29 1993-08-24 Hoffmann-La Roche Inc. Substituted aminoalkyl biphenyl compounds

Also Published As

Publication number Publication date
IL110254A0 (en) 1994-10-21
KR100312441B1 (ko) 2002-10-31
US5495048A (en) 1996-02-27
CA2126518A1 (fr) 1995-01-15
RU94026094A (ru) 1996-05-20
HU9402085D0 (en) 1994-09-28
RU2141942C1 (ru) 1999-11-27
ATE191142T1 (de) 2000-04-15
DE59409248D1 (de) 2000-05-04
JPH0753479A (ja) 1995-02-28
UA37199C2 (uk) 2001-05-15
CN1103781A (zh) 1995-06-21
PT636367E (pt) 2000-07-31
PH31092A (en) 1998-02-05
NO309924B1 (no) 2001-04-23
ES2144471T3 (es) 2000-06-16
NO942606L (no) 1995-01-16
CN1087934C (zh) 2002-07-24
DK0636367T3 (da) 2000-07-31
EP0636367A1 (fr) 1995-02-01
CZ167694A3 (en) 1995-01-18
CZ288518B6 (cs) 2001-07-11
NZ260968A (en) 1996-06-25
US5574071A (en) 1996-11-12
AU684507B2 (en) 1997-12-18
JP2519022B2 (ja) 1996-07-31
GR3033645T3 (en) 2000-10-31
KR960014096A (ko) 1996-05-22
EP0636367B1 (fr) 2000-03-29
TW438774B (en) 2001-06-07
HUT70835A (en) 1995-11-28
CA2126518C (fr) 2006-11-21
NO942606D0 (no) 1994-07-12
US5637771A (en) 1997-06-10
AU6735894A (en) 1995-01-27

Similar Documents

Publication Publication Date Title
EP0210849B1 (fr) 2-Hydroxy-3-phénoxypropylamines
IL110254A (en) The use of tertiary ketopenalkylamines in the manufacture of drugs that lower the level of certain new tertiary cholesterololactofenalkylamines
US4927836A (en) Amide derivatives
EP0178874B1 (fr) Alkylsulfonamidophénylalkylamines
CA1255667A (fr) Derives de dichloroaniline
IE47237B1 (en) Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
US12528761B2 (en) Thyromimetics
EP0410359A1 (fr) Dérivés substitués de l'aminoalkoxybenzène
JP4225791B2 (ja) 肝癌の予防または再発抑制剤
NZ202728A (en) 2-(phenylmethylene)-cycloalkylamine and-azetidine derivatives
EP0220878A2 (fr) Composés d'éthanolamine
DK163182B (da) Dialkylaminoalkoxybenzylalkoholderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat og fremgangsmaade til fremstilling deraf
BE1004530A3 (fr) Nouveaux derives de l'aminopropanol, procede pour leur preparation et compositions pharmaceutiques contenant de tels derives.
IE59466B1 (en) Dichloroaniline derivatives
KR100195648B1 (ko) 치환된 아미노알킬벤젠 유도체
CN110372571A (zh) 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物
IE48847B1 (en) Cyclohexadiene derivatives
JPS58159444A (ja) ２−（フエニルメチレン）シクロアルキルアミン類および−アゼチジン類
PL176197B1 (pl) Nowe fenyloalkiloaminy oraz środek leczniczy obniżający poziom cholesterolu
RU2033991C1 (ru) Производные аминоалкилбензола или их фармацевтически приемлемые соли с кислотами
KR830001683B1 (ko) 4급 암모늄 부정맥 치료제의 제조방법
US20050054641A1 (en) Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
US5300527A (en) Alkylamino-and alkylamino alkyl diarylketones
EP0219350A2 (fr) Composés d'éthanolamine
EP0362264A1 (fr) Nouveaux esters d'aralkyle et leurs procedes de preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees